Dawn Marie Stull PharmD., BCOP scientific director and lead of INSIGHT MM at Takeda Oncology, discusses the INSIGHT MM (multiple myeloma) study, the largest pharmaceutical company-sponsored global observational study of its kind in multiple myeloma.
Shawn Singh, CEO of VistaGen Therapeutics discusses their pipeline which includes nasal sprays that work like spritzers to the brain, for instance, PH10, an experimental antidepressant that completed a phase 2a study and received a patent and PH94B for Social Anxiety Disorder.
Dr. Aswini Misro talks about building a free artificial intelligence application to reduce monopoly in healthcare and to educate the patient.
Dr. Jeff Leighton, a professional pharmacologist, discusses the science behind the newly launched REVIVE, a non-caffeinated energy supplement.
Terri Milton discusses the excessive amounts of fat build-up in the liver causing liver inflammation and damage.
Dr. Christi Heck discusses drug-resistant epilepsy and vagus nerve stimulation (VNS) therapy.
The range of options for children aged six months & older & the first & only adjuvanted seasonal influenza vaccine developed for people aged 65 & older.
Alexis Brink, Author of “THE ART OF JIN SHIN: The Japanese Practice of Healing with Your Fingertips”, talks about the practice of Jin Shin, & its benefits.
Dr. Regina Berkovich discusses Mayzent, the first and only pill studied and proven in secondary progressive multiple sclerosis (SPMS).
Patrick Connor at AstraZeneca, discusses The Lung Ambition Alliance and their goal to double the 5-year survival rate and to one day eliminate lung cancer.